News

ICR and Spectacle Strategy Announce New Research Report: The 2020 Cannabis Consumer

April 20, 2020

NEW YORK–(BUSINESS WIRE)–ICR, a leading strategic communications and advisory firm, and Spectacle Strategy, a creative strategy consultancy specializing in branding, consumer insights, innovation and customer experience, released today the firms’ co-authored research report, “The 2020 Cannabis Consumer,” which provides an extensive look at contemporary cannabis consumers in legalized markets across the U.S., including current consumption…

Details

Nearly $3 Billion of U.S. Cannabis-Infused Product Sales Predicted for 2020

April 20, 2020

WASHINGTON–(BUSINESS WIRE)–New Frontier Data, the global authority in data, analytics and business intelligence on the cannabis industry, releases Cannabis-Infused Products: U.S. Consumer Experience and Demand, Volume 1, in partnership with SōRSE Technology. The report analyzes the performance, consumers and manufacturing processes of the infused products market, as well as the ways cannabis companies are shaping…

Details

Polycystic Ovarian Syndrome Treatment Market Report 2020 – ResearchAndMarkets.com

April 20, 2020

DUBLIN–(BUSINESS WIRE)–The “Polycystic Ovarian Syndrome Treatment Market Global Report 2020-30” report has been added to ResearchAndMarkets.com’s offering. The global polycystic ovarian syndrome treatment market was worth $3.83 billion in 2019. North America was the largest region. This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and…

Details

2020 United States Drugs of Abuse Testing Market for 12 Assays: Supplier Shares & Strategies, Volume & Sales Segment Forecasts – ResearchAndMarkets.com

April 20, 2020

DUBLIN–(BUSINESS WIRE)–The “2020 US Drugs of Abuse Testing Market for 12 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts” report has been added to ResearchAndMarkets.com’s offering. This 262-page report provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles…

Details

Redwood Green Corp. Schedules Investor Day Webinar on April 21, 2020

April 20, 2020

DENVER–(BUSINESS WIRE)–Redwood Green Corp. (OTC:RDGC) announced today that it will host an Investor Day Webinar accessible for all shareholders and potential investors on Tuesday, April 21, 2020 at 4:00pm EDT. The Company will present the current status of its operations and Corporate Strategy for 2020. Interested individuals must register at the following link: REGISTRATION FOR…

Details

Survey: How COVID-19 is Changing the Workplace

April 20, 2020

ALEXANDRIA, Va.–(BUSINESS WIRE)–Following unprecedented reports of unemployment, new research released by SHRM (Society for Human Resource Management) sheds light on how the coronavirus is disrupting workplaces. The survey polled more than 2,200 human resource professionals to understand the top challenges employers are facing and examine the actions workplaces have taken to adapt to today’s evolving…

Details

Operator of Third-largest Dispensary in the U.S. Celebrates 4/20 All Month Long With Virtual Bingo & Tours, a Drive-thru Unveiling, Growth & Expansion Plans, a Hiring Drive & a Recipe Contest

April 20, 2020

PHOENIX–(BUSINESS WIRE)–The Mint Dispensary Celebrates 4/20 Differently This Year

Halo Announces Closing of the Previously Announced Private Placement For CAD $425,000 and Completion of Acquisition of Nasalbinoid Natural Devices Corp.

April 19, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce, further to the press release dated April 6, 2020, it has completed the acquisition of all of the common shares of Nasalbinoid Natural Devices Corp. (“Nasalbinoid”). The Company, through its wholly-owned subsidiary, 1245316 B.C. Ltd. (“Subco”) acquired…

Details

ANADARKO 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Anadarko Petroleum Corporation, now a wholly-owned subsidiary of Occidental Petroleum Corp.

April 17, 2020

NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until April 20, 2020 to file lead plaintiff applications in a securities class action lawsuit against Anadarko Petroleum Corporation, now a wholly-owned…

Details

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against iAnthus Capital Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

April 17, 2020

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”) (OTC: ITHUF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange…

Details

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of iAnthus Capital Holdings, Inc. (ITHUF) on Behalf of Investors

April 17, 2020

LOS ANGELES–(BUSINESS WIRE)—- $ITHUF #fraud–Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of iAnthus Capital Holdings, Inc. on Behalf of Investors

Global CBD Hemp Oil Markets, 2020-2025: Growth Insights, Trends and Segment Forecasts – ResearchAndMarkets.com

April 17, 2020

DUBLIN–(BUSINESS WIRE)–The “Global CBD Hemp Oil Markets 2020-2025: Growth Insights, Trends and Segment Forecasts” report has been added to ResearchAndMarkets.com’s offering. The World’s CBD hemp oil market is projected to grow at a significant rate owing to the increase in the need for plant-based pain relief medication and the prevalence of mood-related neurological disorders in…

Details